Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor

B Brus, U Kosak, S Turk, A Pislar… - Journal of medicinal …, 2014 - ACS Publications
Butyrylcholinesterase (BChE) is regarded as a promising drug target as its levels and activity
significantly increase in the late stages of Alzheimer's disease. To discover novel BChE …

Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.

B Brus, U Košak, S Turk, A Pišlar, N Coquelle… - Journal of Medicinal …, 2014 - hal.science
Butyrylcholinesterase (BChE) is regarded as a promising drug target as its levels and activity
significantly increase in the late stages of Alzheimer's disease. To discover novel BChE …

[DOC][DOC] Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor

B Brus, U Košak, S Turk, A Pišlar, N Coquelle, J Kos… - researchgate.net
Butyrylcholinesterase (BChE) is regarded as a promising drug target as its levels and activity
significantly increase in the late stages of Alzheimer's disease. To discover novel BChE …

Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor

B Brus, U Kosak, S Turk, A Pislar… - Journal of Medicinal …, 2014 - hero.epa.gov
Butyrylcholinesterase (BChE) is regarded as a promising drug target as its levels and activity
significantly increase in the late stages of Alzheimer's disease. To discover novel BChE …

Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.

B Brus, U Košak, S Turk, A Pišlar… - Journal of Medicinal …, 2014 - europepmc.org
Butyrylcholinesterase (BChE) is regarded as a promising drug target as its levels and activity
significantly increase in the late stages of Alzheimer's disease. To discover novel BChE …

Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.

B Brus, U Košak, S Turk, A Pišlar… - Journal of …, 2014 - hal.univ-grenoble-alpes.fr
Butyrylcholinesterase (BChE) is regarded as a promising drug target as its levels and activity
significantly increase in the late stages of Alzheimer's disease. To discover novel BChE …

[PDF][PDF] Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor

B Brus, U Košak, S Turk, A Pišlar, N Coquelle, J Kos… - 2014 - academia.edu
Butyrylcholinesterase (BChE) is regarded as a promising drug target as its levels and activity
significantly increase in the late stages of Alzheimer, s disease. To discover novel BChE …

Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor

B Brus, U Košak, S Turk, A Pišlar… - Journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Butyrylcholinesterase (BChE) is regarded as a promising drug target as its levels and activity
significantly increase in the late stages of Alzheimer's disease. To discover novel BChE …

[引用][C] Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor

B Brus, U Košak, S Turk, A Pišlar, N Coquelle… - Journal of Medicinal …, 2014 - cir.nii.ac.jp
Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective
Butyrylcholinesterase Inhibitor | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.

B Brus, U Košak, S Turk, A Pišlar… - Journal of …, 2014 - hal.univ-grenoble-alpes.fr
Butyrylcholinesterase (BChE) is regarded as a promising drug target as its levels and activity
significantly increase in the late stages of Alzheimer's disease. To discover novel BChE …